Next-generation sequencing discriminates myelodysplastic/myeloproliferative neoplasms from paraneoplastic leukemoid reaction in cancer patients with hyperleukocytosis.
about
Next-generation sequencing discriminates myelodysplastic/myeloproliferative neoplasms from paraneoplastic leukemoid reaction in cancer patients with hyperleukocytosis.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Next-generation sequencing dis ...... tients with hyperleukocytosis.
@en
Next-generation sequencing dis ...... tients with hyperleukocytosis.
@nl
type
label
Next-generation sequencing dis ...... tients with hyperleukocytosis.
@en
Next-generation sequencing dis ...... tients with hyperleukocytosis.
@nl
prefLabel
Next-generation sequencing dis ...... tients with hyperleukocytosis.
@en
Next-generation sequencing dis ...... tients with hyperleukocytosis.
@nl
P2093
P2860
P50
P1433
P1476
Next-generation sequencing dis ...... atients with hyperleukocytosis
@en
P2093
Aline Renneville
Antoine Hollebecque
Benjamin Besse
Christophe Marzac
Florence Pasquier
Jean-Baptiste Micol
Jean-Edouard Martin
Sophie Cotteret
Veronique Saada
P2860
P304
P356
10.1080/10428194.2017.1397669
P577
2017-11-08T00:00:00Z